|
|
| Model Number |
PCO2520OSX |
| Medical Device Problem Codes |
Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Adhesion(s) (1695); Diarrhea (1811); Fistula (1862); Foreign Body Reaction (1868); Failure of Implant (1924); Nausea (1970); Pain (1994); Hernia (2240); Urinary Frequency / Polyuria (2275); Discomfort (2330); Obstruction/Occlusion (2422); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced dense and hardened adhesions, chronic obstruction, severe and chronic pain and discomfort, hernia recurrence, mesh failure, and foreign body giant cell reaction.Post-operative patient treatment included additional surgery and removal of mesh.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: h6 (patient codes, device codes), additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced dense and hardened adhesions, chronic obstruction, severe and chronic pain and discomfort, hernia recurrence, mesh failure, fistula, nausea, diarrhea, urinary frequency, discomfort, and foreign body giant cell reaction.Post-operative patient treatment included additional surgery and removal of mesh, medication, hernia repair with new mesh.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: b5, b7, h4 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced dense and hardened adhesions, chronic obstruction, severe and chronic pain, discomfort, hernia recurrence, mesh failure, fistula, nausea, diarrhea, urinary frequency, and foreign body giant cell reaction.Post-operative patient treatment included revision surgery, reduction and repair of obstructing hiatal hernia, suture hernia repair, removal of mesh, resection of failed mesh, resection of titanium screws, bilateral myofascial release, medication, and hernia repair with new mesh.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced dense and hardened adhesions, chronic obstruction, severe and chronic pain, discomfort, hernia recurrence, mesh failure, fistula, nausea, diarrhea, urinary frequency, foreign body giant cell reaction, hostile abdomen, renal insufficiency, baseline frailty, unsteady on feet, <(>&<)> loss of domain.Post-operative patient treatment included revision surgery, reduction and repair of obstructing hiatal hernia, suture hernia repair, mesh revision, removal of mesh, resection of failed mesh, resection of titanium screws, bilateral myofascial release, medication, and hernia repair with new mesh.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: a1, a5b, b2, b5, b6, b7, h6 (ime e2402: hostile abdomen, renal insufficiency, baseline frailty, loss of domain), <(>&<)> additional codes medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|